Thoracic Cancer (Aug 2023)

Rapidly developing intrathoracic low‐grade fibromyxoid sarcoma: A case report

  • Eri Narukami,
  • Takashi Anayama,
  • Marino Yamamoto,
  • Yujiro Bunno,
  • Ryohei Miyazaki,
  • Hironobu Okada,
  • Mitsuko Iguchi

DOI
https://doi.org/10.1111/1759-7714.15020
Journal volume & issue
Vol. 14, no. 23
pp. 2314 – 2319

Abstract

Read online

Abstract Low‐grade fibromyxoid sarcoma (LGFMS) is a rare mesenchymal tumor that primarily arises in the limbs and trunk of young adults, and rarely in the thoracic cavity. An 84‐year‐old Japanese woman presented with a right intrathoracic mass which was 8 cm in size. CT‐guided needle biopsy did not provide a definitive diagnosis. Perioperatively, a mass was found in the right lower lobe of the lung and was suspected to have invaded the chest wall at the sixth–eighth ribs. A right lower lobectomy and combined chest wall resection were performed. Microscopic examination revealed that the tumor was a low‐grade spindle cell tumor originating from the pleura demonstrating focal invasion of the lung. The tumor exhibited positivity for MUC4, and FUS gene translocation was confirmed through fluorescence in situ hybridization. Unfortunately, 10 months postoperatively, tumor recurrence was noted as peritoneal dissemination, and the patient passed away 13 months postoperatively. Although LGFMS may be diagnosed histologically as a low‐grade tumor by needle biopsy, in this case, it was highly malignant. Postoperative long‐term regular medical follow‐up is recommended considering the highly malignant nature of the tumor and the high risk of local recurrence and pulmonary metastasis.

Keywords